423 related articles for article (PubMed ID: 9500554)
21. Microphthalmia-associated transcription factor (MITF): multiplicity in structure, function, and regulation.
Shibahara S; Takeda K; Yasumoto K; Udono T; Watanabe K; Saito H; Takahashi K
J Investig Dermatol Symp Proc; 2001 Nov; 6(1):99-104. PubMed ID: 11764295
[TBL] [Abstract][Full Text] [Related]
22. Functional analysis of a SOX10 gene mutation associated with Waardenburg syndrome II.
Wang XP; Hao ZQ; Liu YL; Mei LY; He CF; Niu ZJ; Sun J; Zhao YL; Feng Y
Biochem Biophys Res Commun; 2017 Nov; 493(1):258-262. PubMed ID: 28893539
[TBL] [Abstract][Full Text] [Related]
23. Mutations in PAX3 associated with Waardenburg syndrome type I.
Baldwin CT; Lipsky NR; Hoth CF; Cohen T; Mamuya W; Milunsky A
Hum Mutat; 1994; 3(3):205-11. PubMed ID: 8019556
[TBL] [Abstract][Full Text] [Related]
24. Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A.
Tachibana M
Pigment Cell Res; 1997; 10(1-2):25-33. PubMed ID: 9170159
[TBL] [Abstract][Full Text] [Related]
25. The transcription factor onecut-2 controls the microphthalmia-associated transcription factor gene.
Jacquemin P; Lannoy VJ; O'Sullivan J; Read A; Lemaigre FP; Rousseau GG
Biochem Biophys Res Commun; 2001 Aug; 285(5):1200-5. PubMed ID: 11478782
[TBL] [Abstract][Full Text] [Related]
26. A novel mutation in the PAX3 gene causes Waardenburg syndrome type I in an Iranian family.
Jalilian N; Tabatabaiefar MA; Farhadi M; Bahrami T; Noori-Daloii MR
Int J Pediatr Otorhinolaryngol; 2015 Oct; 79(10):1736-40. PubMed ID: 26279250
[TBL] [Abstract][Full Text] [Related]
27. Four mutations in MITF, SOX10 and PAX3 genes were identified as genetic causes of waardenburg syndrome in four unrelated Iranian patients: case report.
Zardadi S; Rayat S; Doabsari MH; Alishiri A; Keramatipour M; Shahri ZJ; Morovvati S
BMC Pediatr; 2021 Feb; 21(1):70. PubMed ID: 33557787
[TBL] [Abstract][Full Text] [Related]
28. A cascade of genes related to Waardenburg syndrome.
Tachibana M
J Investig Dermatol Symp Proc; 1999 Sep; 4(2):126-9. PubMed ID: 10536986
[TBL] [Abstract][Full Text] [Related]
29. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A.
Nobukuni Y; Watanabe A; Takeda K; Skarka H; Tachibana M
Am J Hum Genet; 1996 Jul; 59(1):76-83. PubMed ID: 8659547
[TBL] [Abstract][Full Text] [Related]
30. Apparent digenic inheritance of Waardenburg syndrome type 2 (WS2) and autosomal recessive ocular albinism (AROA).
Morell R; Spritz RA; Ho L; Pierpont J; Guo W; Friedman TB; Asher JH
Hum Mol Genet; 1997 May; 6(5):659-64. PubMed ID: 9158138
[TBL] [Abstract][Full Text] [Related]
31. Direct regulation of the Microphthalmia promoter by Sox10 links Waardenburg-Shah syndrome (WS4)-associated hypopigmentation and deafness to WS2.
Lee M; Goodall J; Verastegui C; Ballotti R; Goding CR
J Biol Chem; 2000 Dec; 275(48):37978-83. PubMed ID: 10973953
[TBL] [Abstract][Full Text] [Related]
32. Waardenburg syndrome type 1.
Karaman A; Aliagaoglu C
Dermatol Online J; 2006 Mar; 12(3):21. PubMed ID: 16638435
[TBL] [Abstract][Full Text] [Related]
33. Expression of genes for microphthalmia isoforms, Pax3 and MSG1, in human melanomas.
Vachtenheim J; Novotná H
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):1075-82. PubMed ID: 10644012
[TBL] [Abstract][Full Text] [Related]
34. Mutations in the paired domain of the human PAX3 gene cause Klein-Waardenburg syndrome (WS-III) as well as Waardenburg syndrome type I (WS-I).
Hoth CF; Milunsky A; Lipsky N; Sheffer R; Clarren SK; Baldwin CT
Am J Hum Genet; 1993 Mar; 52(3):455-62. PubMed ID: 8447316
[TBL] [Abstract][Full Text] [Related]
35. The clinical and genetic research of Waardenburg syndrome type I and II in Chinese families.
Liu Q; Cheng J; Lu Y; Zhou J; Wang L; Yang C; Yang G; Yang H; Cao J; Zhang Z; Sun Y
Int J Pediatr Otorhinolaryngol; 2020 Mar; 130():109806. PubMed ID: 31812001
[TBL] [Abstract][Full Text] [Related]
36. Mutations in the PAX3 gene causing Waardenburg syndrome type 1 and type 2.
Tassabehji M; Read AP; Newton VE; Patton M; Gruss P; Harris R; Strachan T
Nat Genet; 1993 Jan; 3(1):26-30. PubMed ID: 8490648
[TBL] [Abstract][Full Text] [Related]
37. [Clinical and molecular genetic investigation of Waardenburg syndrome type 1].
Markova TG; Megrelishvilli SM; Shevtsov SP; Shvarts EI
Vestn Otorinolaringol; 2003; (1):17-9. PubMed ID: 12666593
[TBL] [Abstract][Full Text] [Related]
38. Deletions at the SOX10 gene locus cause Waardenburg syndrome types 2 and 4.
Bondurand N; Dastot-Le Moal F; Stanchina L; Collot N; Baral V; Marlin S; Attie-Bitach T; Giurgea I; Skopinski L; Reardon W; Toutain A; Sarda P; Echaieb A; Lackmy-Port-Lis M; Touraine R; Amiel J; Goossens M; Pingault V
Am J Hum Genet; 2007 Dec; 81(6):1169-85. PubMed ID: 17999358
[TBL] [Abstract][Full Text] [Related]
39. First report of Klein-Waardenburg Syndrome in Iran and a novel pathogenic splice site variant in PAX3 gene.
Saberi M; Golchehre Z; Salmani H; Karamzade A; Tabatabaie SZ; Keramatipour M
Int J Pediatr Otorhinolaryngol; 2018 Oct; 113():229-233. PubMed ID: 30173992
[TBL] [Abstract][Full Text] [Related]
40. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance.
Takeda K; Takemoto C; Kobayashi I; Watanabe A; Nobukuni Y; Fisher DE; Tachibana M
Hum Mol Genet; 2000 Jan; 9(1):125-32. PubMed ID: 10587587
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
